The appointment of engineer Giuseppe Viglialoro, Business Development Director at Technoscience – Pontine Science and Technology Park, in the Scientific Council of the Rome Technopole Foundation represents a highly significant step for the Park's positioning within the national innovation ecosystem.
This is not merely a personal recognition. Giuseppe's presence on the Scientific Council confirms Technoscience's growing role in a strategic network bringing together universities, public research bodies, institutions and major industrial players active in the fields of digital transition, energy transition and BioTech-Pharma.
Technoscience in Rome Technopole: An Increasingly Strategic Presence
Rome Technopole is currently one of the most significant infrastructures established to strengthen the connection between research, business and the local area. Its model brings together scientific expertise, industrial capability and institutional vision, with the aim of turning knowledge into applied innovation and competitive development for Lazio and for Italy as a whole.
In this context, Technoscience's presence takes on particular significance. The Pontine Science and Technology Park reaffirms its identity within an ecosystem that includes major universities, national research centres, public institutions and leading companies in energy, aerospace, defence, digital technologies, health, pharmaceuticals and advanced technologies.
Giuseppe Viglialoro on the Scientific Council
Alongside organisations such as Acea, CNR, ENEA, INAIL, INFN, ISS, Sapienza University of Rome, Luiss University, Università Cattolica del Sacro Cuore, University of Rome Tor Vergata, Roma Tre University, Unidata, Area Science Park in Trieste and other leading organisations, Giuseppe's presence on behalf of Technoscience reflects a path of growing authority built through expertise, continuity and the ability to forge connections.
This is precisely where the value of the appointment lies: Technoscience is not taking part in Rome Technopole merely as an observer, but as an organisation capable of contributing to dialogue between applied research, industry, territorial projects and technology transfer. This is an essential function in major innovation ecosystems, where the ability to connect different worlds often becomes as decisive as the production of knowledge itself.
Tags
A National Ecosystem Connecting Research, Industry and Institutions
The appointment to the Scientific Council also follows a path already under way within Rome Technopole: Technoscience had in fact already consolidated its presence on the Foundation's Steering Committee. With Giuseppe Viglialoro joining the Scientific Council, this presence takes a further step forward. The Pontine Science and Technology Park is strengthening its participation in a body called upon to help shape the scientific direction of one of Italy's leading innovation platforms.
Giuseppe's profile fits coherently within this trajectory. His experience in business development, industrial relations, complex innovation programmes, European project development and digital transformation provides expertise that directly supports Technoscience's mission: building bridges between research, business and the local area, and turning technological opportunities into concrete projects.
For Technoscience, this appointment is recognition of its role. It confirms the Park's ability to engage with national and international organisations while maintaining strong local roots. It is precisely this combination of broad vision and operational proximity that makes Technoscience a recognisable player in applied innovation processes.
Technoscience's Value in Major Innovation Networks
Technoscience brings a distinctive culture to this landscape: that of a science park capable of understanding local needs, identifying research trajectories, supporting companies through innovation processes and helping turn expertise into applied value.
For the local area, this appointment is an important signal. It shows that innovation does not belong only to major metropolitan hubs or large industrial groups, but can also be generated, supported and enhanced by organisations capable of participating competently in national research and technological development networks.
The Pontine Science and Technology Park is thus strengthening its presence in one of the places where decisive trajectories are being shaped for the future of applied research, health, biotech, digital transition and technology transfer.
👉 For more details about the project Rome Technopole, visit the official website: rometechnopole.it.
How we turn ideas into biotech projects
Would you like to understand how we could work together on complex biotech projects, such as the one on glioblastoma? Below is a selection of in-depth pages on biopharmaceutical pipelines, biobanks, data management and AI, telemedicine, precision cardiology and TRL pathways. They are the starting point for turning a good idea into an operational pathway, from the initial concept through to clinical validation and market entry.
Careers & Skills
Industry & Technology Transfer
GREEN & AGRI-BIOTECH
Biopharmaceuticals & Therapies
Biotechnology for Health
Frequently Asked Questions
Choose Technoscience!
To rapidly assess a project in biotech and translational medicine - from oncology and neuroscience to precision cardiology and telemedicine - we ask for: a clear clinical or industrial question, the available evidence (including negative findings), access to data and samples where applicable, a draft protocol (including ethical aspects), and hypotheses on biomarkers and endpoints. In return, we offer technical and scientific due diligence, the design of a credible TRL pathway and, where appropriate, support with regulatory strategy, validation and scalability.
Biotech FAQ
The questions you ask us most often
It is an approach that defines the the actual biology of the disease (tissues, markers and omics profiles where indicated) and links it to diagnostic and therapeutic decisions diagnostic and therapeutic personalised. It does not stop at generic classifications or guidelines applied wholesale: it builds a individual pathway measurable through robust clinical endpoints.
An enabling role. The biobanks ensure traceable and comparable samples; the omics broaden the understanding of the underlying mechanisms (inflammatory, metabolic and genetic). When integrated with rigorous protocols and real-world data, make reproducible the evidence and accelerate translation towards clinical trials or clinical adoption.
